Aristides Capital’s Rockwell Medical RMTI Stock Holding History

Aristides Capital’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-201	Closed	-$54K	–	221
2019 Q4	$54K	Buy	+201	New	+$50.5K	0.04%	217

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

Aristides Capital's RMTI Position: Q1 2020 in Review

Aristides Capital sold out of Rockwell Medical (RMTI) in Q1 2020, closing a stake of 201 shares — an estimated $54K sold.

Aristides Capital first reported a position in RMTI in Q4 2019 and held it in 1 quarter. The position peaked at $54K in Q4 2019. 79 funds tracked by Wall St. Rank hold RMTI as of Q1 2020.

Aristides Capital reported no remaining Rockwell Medical position as of Q1 2020 after selling out during the quarter.
Aristides Capital sold 201 Rockwell Medical shares in Q1 2020, an estimated $54K.
Aristides Capital first reported a position in Rockwell Medical in Q4 2019 and held it in 1 quarter.
Aristides Capital's Rockwell Medical position peaked at $54K in Q4 2019.
79 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2020.

Based on Aristides Capital's 13F filing for Q1 2020, filed 15 May 2020.